Engagement summary
Client Background
Healthcare Outcomes Performance Company (HOPCo) is a PE-backed orthopedic-management platform executing a multi-state acquisition strategy, including an international patient-application subsidiary.
Engagement Scope
R&M serves as HOPCo's primary technical-accounting partner, addressing variable-interest-entity analysis under ASC 810, full GAAP financial-statement preparation including consolidation, ASC 842 lease implementation, ASC 805 purchase accounting across multiple acquisitions, foreign-currency accounting, and goodwill change-in-treatment analysis.
Services Provided
- ASC 810 variable interest entity analysis
- Annual GAAP financial statement preparation and consolidation
- ASC 842 lease implementation and ongoing accounting
- ASC 805 purchase accounting for multiple acquisitions
- ASC 830 foreign currency accounting — international subsidiary
Valuation context
HOPCo engaged Rivers & Moorehead for independent valuation support under the standard(s) listed above. The engagement provides valuation analyses, supporting models, and written deliverables intended to assist the company and its external auditors with financial reporting under U.S. GAAP.
Valuation scope
- ASC 805 purchase price allocation – identification and fair value measurement of acquired identifiable intangible assets (e.g., customer relationships, trade names, developed technology, non-compete agreements), tangible assets, and assumed liabilities, with residual goodwill calculation and opening balance sheet support.